Back to Atlas
BSemi-durableNootropic/stimulant caution
CMP-0163
Research
AF710B
Cholinergic / Nootropic
Cognitive enhancement and neurodegeneration positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- M1 muscarinic and sigma-1 activity
- Primary market use
- Alzheimer's/cognition
Pharmacology
- Molecular weight (Da)
- ~397
- Oral bioavailability
- Unknown
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Oral
- Evidence level
- Preclinical
- Clinical status
- Research
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
EveryChem nootropic category